This Real Estate Stock Could Stay Red-Hot

The head of the U.S. central bank struck a dovish tone in his congressional testimony

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MARKET RECAP     7/10/2019
Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Stocks Hit New Highs After Powell Signals Rate-Cut Support By Karee Venema Share On Stocks sailed to fresh highs today, as Wall Street cheered congressional testimony from Fed Chair Jerome Powell, which indicated the central bank could be ready to cut interest rates at its July meeting. In front of the House Financial Services Committee , Powell cited concerns over a slowing global economy -- a theme echoed in the Fed's June meeting minutes, which were released mid-afternoon. While the S&P marked its first-ever trek above 3,000 in intraday trading, the Dow and Nasdaq hit all-time peaks, with the latter settling at a record close. Continue reading for more on today's market, including: Why this real estate stock could stay red-hot. Credit Suisse thinks this insurance stock could be cut in half. The big news that boosted T-Mobile. Plus, the stock that tripled today; Delta bulls bet on another earnings win; and a major upgrade for Comcast. >> Continue reading...
LATEST HEADLINES
>> Solar Stock Signaling Strong Summer Ahead SunPower options are attractively priced at the moment, too >> 2 Stocks Surging on New Contracts One stock is up over 300% >> This May Be the Starbucks of Cannabis Click to continue to advertiser's site. >> Calls Pop on AAL; DAL Earnings in Focus American Airlines' update has drawn attention to the sector today >> Unum Group Put Volume Spikes After Bruising Bear Note Credit Suisse just initiated coverage on Unum with an "underperform" rating and a $19 price target ADVERTISEMENT A Rare Opportunity to Turn $1,000 into $1.57 Million On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Market Recap, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Market Recap or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Market Recap? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MARKET RECAP enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com